Dr Nicola Wyatt
Dr Hannah Watson
Dr Dean Allerton
Michelle Bardgett
Dr Emma Clark
et al. | Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: Protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine | 2024 |
|
Sean Carrie
Tony Fouweather
Tara Homer
James O'Hara
Alison Bray
et al. | Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCT | 2024 |
|
Sean Carrie
James O'Hara
Tony Fouweather
Tara Homer
Dr Nikki Rousseau
et al. | Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trial | 2023 |
|
Dr Ge Yu
Stephen Rice
Professor Rakesh Heer
Dr Emma Clark
Professor Luke Vale
et al. | Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non–muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial | 2023 |
|
Dr Emma Clark
Dr Holly Fisher
Jenn Walker
Ruth Wood
Professor Helen Hancock
et al. | Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial | 2023 |
|
Professor Luke Vale
Dr Jing Shen
Dr Emma Clark
| Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: A study protocol for a randomised trial of clinical and cost-effectiveness | 2019 |
|
Dr Emma Clark
Dr Miranda Patterson
Shriya Sharma
Dr Holly Fisher
Denise Howel
et al. | Prostate cancer androgen receptor splice variant 7 biomarker study - A multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol | 2019 |
|
James Grey
Dr Dominic Jones
Laura Wilson
Dr Sirintra Nakjang
Jake Clayton
et al. | Differential regulation of the androgen receptor by protein phosphatase regulatory subunits | 2018 |
|
Dr Emma Clark
Dr Richard Temperley
Amy Barnard
Professor Craig Robson
| p68/DdX5 Supports β-Catenin & RNAP II during Androgen Receptor Mediated Transcription in Prostate Cancer | 2013 |
|
Dr Prabhakar Rajan
Caroline Dalgliesh
Dr Kaveh Emami
Dr Emma Clark
Professor Craig Robson
et al. | Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies | 2009 |
|
Dr Emma Clark
Professor David Elliott
Professor Craig Robson
| Coupling transcription to RNA processing via the p68 DEAD box RNA helicase androgen receptor co-activator in prostate cancer | 2008 |
|
Dr Emma Clark
Dr Anne Coulson
Caroline Dalgliesh
Dr Prabhakar Rajan
Professor Rakesh Heer
et al. | The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer | 2008 |
|
Catriona Manville
Dr Emma Clark
Dr Kay Padget
james Harvey
Dr Nick Morris
et al. | Bioinformatic analysis of topoisomerase II binding sites | 2007 |
|
Dr Emma Clark
| Topoisomerase IIa human genomic binding sites | 2006 |
|
Dr Emma Clark
| Thyroid hormone action in the placenta | 2005 |
|
Dr Emma Clark
Dr Judith Bulmer
| Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies | 2003 |
|
